by Team Small News | Oct 27, 2025 | Cipla, Pharma
Cipla Health, a leading healthcare company, has launched a new brand called Unfold, marking its entry into the sexual wellness segment. The brand’s design and visual identity were developed by dCell, a design agency, to redefine how intimacy is represented in... by Team Small News | Oct 27, 2025 | Cipla, Pharma
India’s weight-loss market has welcomed a new player with the launch of ‘Yurpeak’ by Cipla, a popular pharmaceutical company. Yurpeak is the brand name given to the medication Mounjaro, which has been approved by the US FDA for the treatment of type... by Team Small News | Oct 27, 2025 | Biocon, Pharma
In a bid to address the concerns of industrialists over Bengaluru’s poor infrastructure, Deputy Chief Minister DK Shivakumar held a meeting with prominent business leaders, including Biocon founder Kiran Mazumdar-Shaw and former Infosys CFO Mohandas Pai. The... by Team Small News | Oct 25, 2025 | Apollo Hospital, Pharma
Upasana Kamineni Konidela is a renowned businesswoman, philanthropist, and spouse of South Indian superstar Ram Charan Teja. Born on July 20, 1989, in Hyderabad, she hails from one of India’s most influential families. Her great-grandfather, Dr. Prathap C.... by Team Small News | Oct 25, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Ropivacaine Hydrochloride Injection USP, a generic version of Naropin Injection, in November 2025. The new product will be available in three strengths: 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5... by Team Small News | Oct 24, 2025 | Biocon, Pharma
Biocon Biologics Ltd, a global biosimilars company, has announced that Health Canada has granted approval for Yesintek, a biosimilar to Stelara, for the treatment of several moderate to severe autoimmune diseases. The approval includes both subcutaneous and...